EGFR mutant NSCLC now reflects an amended view of oncogene addiction [129], one that can be escaped following the selective pressure applied by EGFR inhibitors due to heterogeneity within the tumor as well as epigenetic and genetic adaptations. This evidence concerns the gene EGFR and non-small cell lung carcinoma.